The Role of Serenoa repens in the Clinical Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Context: Lower urinary tract symptoms (LUTS) are almost universal in men aged >50 yr. As men become more symptomatic, they frequently want to take either supplements or medications to improve their condition or to prevent it from worsening. Objective: To examine and to assess the efficacy and the role of Serenoa repens products in the clinical management of LUTS due to benign prostatic hyperplasia (BPH; BPH/LUTS). Evidence acquisition: Review was undertaken of all articles published on phytotherapies in the urologic literature from 1990 to the present. Evidence synthesis: Only randomized trials were included in this analysis. Special attention was given to the three major meta-analyses on this topic, and the large randomized comparative and placebo-controlled trials were highlighted. Conclusions: Serenoa repens products are a first-line intervention, usually patient initiated, in the management of BPH/LUTS. These products are generally considered very safe and have minimal side effects. The magnitude of their efficacy is still to be determined.

Original languageEnglish (US)
Pages (from-to)894-897
Number of pages4
JournalEuropean Urology, Supplements
Volume8
Issue number13
DOIs
StatePublished - Dec 2009
Externally publishedYes

Fingerprint

Serenoa
Lower Urinary Tract Symptoms
Prostatic Hyperplasia
Phytotherapy
Meta-Analysis
Placebos

Keywords

  • Benign prostatic hyperplasia
  • Saw palmetto berry extract
  • Serenoa repens

ASJC Scopus subject areas

  • Urology

Cite this

@article{e0f8572b887242d3985a2f323f6e2050,
title = "The Role of Serenoa repens in the Clinical Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia",
abstract = "Context: Lower urinary tract symptoms (LUTS) are almost universal in men aged >50 yr. As men become more symptomatic, they frequently want to take either supplements or medications to improve their condition or to prevent it from worsening. Objective: To examine and to assess the efficacy and the role of Serenoa repens products in the clinical management of LUTS due to benign prostatic hyperplasia (BPH; BPH/LUTS). Evidence acquisition: Review was undertaken of all articles published on phytotherapies in the urologic literature from 1990 to the present. Evidence synthesis: Only randomized trials were included in this analysis. Special attention was given to the three major meta-analyses on this topic, and the large randomized comparative and placebo-controlled trials were highlighted. Conclusions: Serenoa repens products are a first-line intervention, usually patient initiated, in the management of BPH/LUTS. These products are generally considered very safe and have minimal side effects. The magnitude of their efficacy is still to be determined.",
keywords = "Benign prostatic hyperplasia, Saw palmetto berry extract, Serenoa repens",
author = "Lowe, {Franklin C.}",
year = "2009",
month = "12",
doi = "10.1016/j.eursup.2009.11.006",
language = "English (US)",
volume = "8",
pages = "894--897",
journal = "European Urology, Supplements",
issn = "1569-9056",
publisher = "Elsevier",
number = "13",

}

TY - JOUR

T1 - The Role of Serenoa repens in the Clinical Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

AU - Lowe, Franklin C.

PY - 2009/12

Y1 - 2009/12

N2 - Context: Lower urinary tract symptoms (LUTS) are almost universal in men aged >50 yr. As men become more symptomatic, they frequently want to take either supplements or medications to improve their condition or to prevent it from worsening. Objective: To examine and to assess the efficacy and the role of Serenoa repens products in the clinical management of LUTS due to benign prostatic hyperplasia (BPH; BPH/LUTS). Evidence acquisition: Review was undertaken of all articles published on phytotherapies in the urologic literature from 1990 to the present. Evidence synthesis: Only randomized trials were included in this analysis. Special attention was given to the three major meta-analyses on this topic, and the large randomized comparative and placebo-controlled trials were highlighted. Conclusions: Serenoa repens products are a first-line intervention, usually patient initiated, in the management of BPH/LUTS. These products are generally considered very safe and have minimal side effects. The magnitude of their efficacy is still to be determined.

AB - Context: Lower urinary tract symptoms (LUTS) are almost universal in men aged >50 yr. As men become more symptomatic, they frequently want to take either supplements or medications to improve their condition or to prevent it from worsening. Objective: To examine and to assess the efficacy and the role of Serenoa repens products in the clinical management of LUTS due to benign prostatic hyperplasia (BPH; BPH/LUTS). Evidence acquisition: Review was undertaken of all articles published on phytotherapies in the urologic literature from 1990 to the present. Evidence synthesis: Only randomized trials were included in this analysis. Special attention was given to the three major meta-analyses on this topic, and the large randomized comparative and placebo-controlled trials were highlighted. Conclusions: Serenoa repens products are a first-line intervention, usually patient initiated, in the management of BPH/LUTS. These products are generally considered very safe and have minimal side effects. The magnitude of their efficacy is still to be determined.

KW - Benign prostatic hyperplasia

KW - Saw palmetto berry extract

KW - Serenoa repens

UR - http://www.scopus.com/inward/record.url?scp=72049089302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72049089302&partnerID=8YFLogxK

U2 - 10.1016/j.eursup.2009.11.006

DO - 10.1016/j.eursup.2009.11.006

M3 - Article

VL - 8

SP - 894

EP - 897

JO - European Urology, Supplements

JF - European Urology, Supplements

SN - 1569-9056

IS - 13

ER -